September 2026

Strides Pharma Science Limited is a Bengaluru-headquartered global pharmaceutical company established in 1990. The company develops and manufactures IP-led niche and complex generic medicines and serves regulated and emerging markets across 100+ countries. Strides has capabilities across multiple dosage forms, including tablets, capsules, sachets, liquids, nasal sprays, topical products and other specialized formulations. Its R&D activities focus on complex generics, novel drug-delivery systems and differentiated formulations.

Walk-in Recruitment Drive @ Bengaluru

Swiss Parenterals Limited is an Ahmedabad-based pharmaceutical company specializing in the development and manufacturing of generic and specialty pharmaceutical products, particularly sterile injectables. The company has more than 25 years of experience and operates as a dossier-driven pharmaceutical business serving international markets.  Swiss focuses on sterile injectable products, including liquid vials, lyophilized products and other complex dosage forms.

H&H Healthcare and Cosmetics Pvt. Ltd. is a B2B healthcare and contract development and manufacturing organization (CDMO) based in Madhya Pradesh, with its manufacturing facility located at Smart Industrial Park, Pithampur. The company develops and manufactures nutraceutical, herbal, Ayurvedic and healthcare products, with capabilities covering R&D, formulation development, manufacturing, packaging and private-label solutions.

Kusum Group of Companies is a global pharmaceutical group headquartered in New Delhi, India, with manufacturing and R&D operations across multiple countries. Through Kusum Healthcare, the group manufactures a range of pharmaceutical formulations including tablets, pellets, topical products and other dosage forms at its facilities in India. The group focuses on providing high-quality, affordable medicines for international markets and operates manufacturing facilities that follow international GMP and quality standards.

The United States has included India, China and Pakistan among 23 countries designated as major drug transit or major illicit drug-producing countries for fiscal year 2027. The designation was submitted to the U.S. Congress on September 15, 2026, as part of the annual U.S. “Major’s List,” which identifies countries considered significant sources or transit points for illicit drugs entering the United States.

Dr. Reddy’s Laboratories has expanded its collaboration with Gilead Sciences through a royalty-free, non-exclusive voluntary licensing agreement covering investigational once-yearly lenacapavir for HIV prevention. The agreement builds on the companies’ existing 2024 licensing arrangement for lenacapavir and is intended to support future manufacturing readiness, technology transfer and supply planning in licensed territories.

Vera Therapeutics has announced final efficacy results from the Phase 3 ORIGIN 3 study of TRUTAKNA™ (atacicept-vymj), reporting sustained stabilization of kidney function and a reduced risk of kidney disease progression in adults with primary IgA nephropathy (IgAN). The final analysis included 428 patients with primary IgAN who were considered at risk of disease progression.

BRIC-Translational Health Science and Technology Institute (THSTI) is an Institute of the Biotechnology Research and Innovation Council, Department of Biotechnology, Ministry of Science & Technology, Govt. of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster located at Faridabad, with the mission to conduct innovative translational research and to develop research collaborations across disciplines and professions to translate concepts into products to improve human health.

Jamia Hamdard is a renowned university in New Delhi, known for its strong focus on education, research, and healthcare sciences. The university offers programmes across pharmaceutical sciences, medicine, allied health sciences, and other disciplines. Its School of Pharmaceutical Education and Research (SPER) is dedicated to pharmaceutical education and research. Jamia Hamdard also undertakes various sponsored research projects in areas related to pharmaceutical and biomedical sciences.

Post: Senior Research Fellow